Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lopalco

Showing results (101-110 of 221) with videos related to

Pageof 23
Sort By:
Frontiers in Pharmacology|January 11, 2020
The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha InhibitorsClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
Clinical and Experimental Rheumatology|April 27, 2019
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective surveyGiuseppe Lopalco, Vincenzo Venerito, Luca Cantarini, et al.
Ocular Immunology and Inflammation|August 28, 2018
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's DiseaseClaudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Clinical Rheumatology|April 3, 2015
The protean ocular involvement in monogenic autoinflammatory diseases: state of the artVittoria Bascherini, Carmela Granato, Giuseppe Lopalco, et al.
Clinical Rheumatology|July 10, 2015
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective studyGiacomo Emmi, Rosaria Talarico, Giuseppe Lopalco, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre studyClaudia Fabiani, Jurgen Sota, Maite Sainz-de-la-Maza, et al.
Frontiers in Microbiology|February 27, 2024
Unraveling the microbiome-metabolome nexus: a comprehensive study protocol for personalized management of Behçet's disease using explainable artificial intelligenceSabina Tangaro, Giuseppe Lopalco, Daniele Sabella, et al.
Clinical Rheumatology|February 11, 2015
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialistsLuca Cantarini, Antonio Vitale, Giulia Bersani, et al.
Internal and Emergency Medicine|December 21, 2022
The diagnostic role of pathergy test in patients with Behçet's disease from the Western EuropeAntonio Vitale, Virginia Berlengiero, Valeria Caggiano, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 31, 2017
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular EdemaClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
Pageof 23

Showing results (101-110 of 221) with videos related to

Sort By:
Pageof 23
Frontiers in Pharmacology|January 11, 2020
The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha InhibitorsClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
Clinical and Experimental Rheumatology|April 27, 2019
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective surveyGiuseppe Lopalco, Vincenzo Venerito, Luca Cantarini, et al.
Ocular Immunology and Inflammation|August 28, 2018
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's DiseaseClaudia Fabiani, Antonio Vitale, Donato Rigante, et al.
Clinical Rheumatology|April 3, 2015
The protean ocular involvement in monogenic autoinflammatory diseases: state of the artVittoria Bascherini, Carmela Granato, Giuseppe Lopalco, et al.
Clinical Rheumatology|July 10, 2015
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet's disease: a multicenter retrospective studyGiacomo Emmi, Rosaria Talarico, Giuseppe Lopalco, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre studyClaudia Fabiani, Jurgen Sota, Maite Sainz-de-la-Maza, et al.
Frontiers in Microbiology|February 27, 2024
Unraveling the microbiome-metabolome nexus: a comprehensive study protocol for personalized management of Behçet's disease using explainable artificial intelligenceSabina Tangaro, Giuseppe Lopalco, Daniele Sabella, et al.
Clinical Rheumatology|February 11, 2015
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialistsLuca Cantarini, Antonio Vitale, Giulia Bersani, et al.
Internal and Emergency Medicine|December 21, 2022
The diagnostic role of pathergy test in patients with Behçet's disease from the Western EuropeAntonio Vitale, Virginia Berlengiero, Valeria Caggiano, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 31, 2017
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular EdemaClaudia Fabiani, Antonio Vitale, Giacomo Emmi, et al.
Pageof 23